MuvonJun 21 minMUVON finishes as Top 3 finalist for the ZKB Pionierpreis 2023 with our tissue engineering therapy With our novel therapy platform for skeletal muscle regeneration, the MUVON team has won the prize of 10k as a runner up for the ZKB...
MuvonFeb 10, 20221 minCEO Deana Mohr presented MUVON in interview for BioInnovation SpotlightOur CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for...
MuvonJun 2, 20211 minMUVON featured by StartuptickerMUVON was featured in an article by Startupticker describing our regenerative approach for the treatment of incontinence and the progress...
MuvonApr 8, 20211 minGreater Zurich Area features MUVON Therapeutics in article on successful biotech innovationsThe University of Zurich (UZH) is advancing biotechnology with innovations. Thanks to a systematic support system and the dynamic...